Effect of the curcuma plus® syrup on the pharmacokinetics of rifampicin in rats

Djoko Wahyono, Arief Rahman Hakim, Purwantiningsih .

Abstract


The research was aimed to observe the effect of Curcuma plus® syrup on rifampicin pharmacokinetics in rats.

The study of interaction Curcuma plus® syrup with rifampicin pharmacokinetics was conducted employing a completely randomized design using male Sprague Dawley rats which were divided into 3 groups (5 rats for each group). The groups were given a single oral rifampicin dose of 50 mg/kg BW as a control group and were confered single oral Curcuma plus syrup 2.7 mL/kg BW one hour before rifampicin and daily dose for 7 days, then is given rifampicin after that. Serial blood samples (0,2 mL) were withdrawn at various interval via the vein for HPLC analysis of unchanged rifampicin in blood. The concentration of rifampicin was determined based on a standard curve, and from the concentration to time data was determined rifampicin pharmacokinetic parameters (Cmaks, tmaks, AUC0-∼, Vd/F, t1/2, ClT dan K).

The results indicated that Curcuma plus® syrup single dose 2.7 mL/kg BW one hour before rifampicin could increased rifampicin volume of distribution by 225.80% (P<0.05) and caused decreased Cmaks 72.81% and AUC0-inf 63.93% (P<0.05), while daily dose Curcuma plus® syrup for 7 days could rise rifampicin total clearance 225.60% (P<0.05) and caused decrease by 76.94% of AUC0-inf (P<0.05).

Key words : pharmacokinetics, Curcuma plus® syrup, rifampicin


Full Text:

Untitled

References


Abdillah, N. F., 1996, Pengaruh praperlakuan kurkuminoid terhadap farmakokinetika salisilamid pada tikus, Skripsi, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.

Anonim, 2003, Uji bioekivalensi tablet FDC RHE (150/75/275) (PT Indofarma tbk) terhadap tablet Rimactane 450 mg (PT Novartis Biochemie) pada sukarelawan sehat, Laporan Penelitian, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.

Anonim, 2006, Pharmaceutical care untuk penyakit tuberkulosis, Ditjet Bina Kefarmasian & Alkes, Departemen Kesehatan RI, Jakarta.

Dollery, S. C., 1991, Therapeutic drugs, vol. 2, T32-T40, Churchill Livingstone, Edinburg.

Donatus, I. A., 1994, Antaraksi kurkumin dan parasetamol : kajian terhadap aspek farmakologi dan toksikologi biotransformasi parasetamol, Disertasi, Program Pascasarjana UGM, Yogyakarta.

Donatus, I. A., 1996, Antaraksi kurkuminoid-teofilin : I. hubungan peringkat dosis kurkuminoid dengan toksisitas akut dan kinerja toksikokinetika teofilin pada tikus, Laporan Penelitian Mandiri, Lembaga Penelitian UGM, Yogyakarta.

Hakim, A. R., 1998, Hubungan kekerapan dan lama masa praperlakuan kurkuminoid dengan toksisitas akut dan kinerja toksikokinetika teofilin pada tikus, Laporan Penelitian DPP/SPP Fak. Farmasi UGM, Yogyakarta.

Jamis-Dow, C. A., Katki, A. G., and Collins, J. M., 1977, Rifampin and Rifabutin and their metabolism by human liver esterase, Xenobiotica, 27, 1015-1024.

Johnston, A. and Woollard, R.C., 1983, Stripe: A computer program for pharmacokinetics, J. of Pharmacol.Methods, 9: 193-199.

Jung, D. T., 1984, Stripe, College of Pharmacy University of Illinois, Chicago.

Mandell, G. L., and Petri, W. A., 1996, Antimicrobial agent (continued), in Goodman Gilman (Ed.), The pharmacological basic of therapeutics, 9th Ed., 1487-1511, McGraw-Hill International Editions, Singapore.

Nastiti, C. M. R. R., 1998, Pengaruh kurkuminoid terhadap farmakokinetika salisilamid dan salisilat pada kelinci, Skripsi, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.

Nurhayati, H., 1997, Pengaruh praperlakuan piperin, air perasan kencur, dan kunyit terhadap farmakokinetika propranolol pada kelinci, Skripsi, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.

Oetari, R. A., 1998, The interactions between curcumin and curcumin analogues and cytochrome P450, molecular and structure-activity relationships studies, Dissertation, GMU, Yogyakarta.

Ratti, B., and Parenti, R., 1981, Quantitative assay of rifampicin and its main metabolite 25- desacetyl rifampicin in human plasma, Journal of Chromatography, 225: 526-531.




DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp163-168

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

web
analytics View My Stats